FDA guidance for bioanalytical run [Regulatives / Guidelines]

posted by xiaodongwang – China, 2017-10-23 12:42 (2671 d 17:13 ago) – Posting: # 17907
Views: 3,455

Dear Samar:

❝ Does this apply for FDA submissin, meaning:can we exclude the ULOQ and the LLOQ from calibration range ?


FDA guidance “Matrix-based standard calibration samples: 75%, or a minimum of six standards, when back-calculated (including ULOQ) should fall within ±15%, except for LLOQ, when it should be ±20% of the nominal value. Values falling outside these limits can be discarded, provided they do not change the established model.

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
100 visitors (0 registered, 100 guests [including 10 identified bots]).
Forum time: 04:56 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5